Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tuomas Mirtti

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
Scientific Reports|January 20, 2017
Erratum: Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomyTeemu D Laajala, Heikki Seikkula, Fatemeh Seyednasrollah, et al.
Plos Computational Biology|March 10, 2023
OSCAR: Optimal subset cardinality regression using the L0-pseudonorm with applications to prognostic modelling of prostate cancerAnni S Halkola, Kaisa Joki, Tuomas Mirtti, et al.
Scientific Reports|October 6, 2017
Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancerMinna Tervahartiala, Pekka Taimen, Tuomas Mirtti, et al.
Scientific Reports|November 3, 2016
Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomyTeemu D Laajala, Heikki Seikkula, Fatemeh Seyednasrollah, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
AI Model for Prostate Biopsies Predicts Cancer SurvivalKevin Sandeman, Sami Blom, Ville Koponen, et al.
Medical Physics|August 14, 2025
A deep learning derived prostate zonal volume-based biomarker from T2-weighted MRI to distinguish between prostate cancer and benign prostatic hyperplasiaZelin Zhang, Qingsong Yang, Rakesh Shiradkar, et al.
Urologic Oncology|December 3, 2014
Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomyHeikki Seikkula, Kari T Syvänen, Samu Kurki, et al.
International Journal of Medical Informatics|November 30, 2019
Cost-effective survival prediction for patients with advanced prostate cancer using clinical trial and real-world hospital registry datasetsMika Murtojärvi, Anni S Halkola, Antti Airola, et al.
Analytical Cellular Pathology (Amsterdam)|October 23, 2010
Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancerLei Gu, Xian-Hua Zhu, Tapio Visakorpi, et al.
European Urology Oncology|May 19, 2019
Patient Experience of Systematic Versus Fusion Prostate BiopsiesJuho T Eineluoto, Petrus Järvinen, Tuomas Kilpeläinen, et al.
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
Scientific Reports|January 20, 2017
Erratum: Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomyTeemu D Laajala, Heikki Seikkula, Fatemeh Seyednasrollah, et al.
Plos Computational Biology|March 10, 2023
OSCAR: Optimal subset cardinality regression using the L0-pseudonorm with applications to prognostic modelling of prostate cancerAnni S Halkola, Kaisa Joki, Tuomas Mirtti, et al.
Scientific Reports|October 6, 2017
Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancerMinna Tervahartiala, Pekka Taimen, Tuomas Mirtti, et al.
Scientific Reports|November 3, 2016
Longitudinal modeling of ultrasensitive and traditional prostate-specific antigen and prediction of biochemical recurrence after radical prostatectomyTeemu D Laajala, Heikki Seikkula, Fatemeh Seyednasrollah, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
AI Model for Prostate Biopsies Predicts Cancer SurvivalKevin Sandeman, Sami Blom, Ville Koponen, et al.
Medical Physics|August 14, 2025
A deep learning derived prostate zonal volume-based biomarker from T2-weighted MRI to distinguish between prostate cancer and benign prostatic hyperplasiaZelin Zhang, Qingsong Yang, Rakesh Shiradkar, et al.
Urologic Oncology|December 3, 2014
Role of ultrasensitive prostate-specific antigen in the follow-up of prostate cancer after radical prostatectomyHeikki Seikkula, Kari T Syvänen, Samu Kurki, et al.
International Journal of Medical Informatics|November 30, 2019
Cost-effective survival prediction for patients with advanced prostate cancer using clinical trial and real-world hospital registry datasetsMika Murtojärvi, Anni S Halkola, Antti Airola, et al.
Analytical Cellular Pathology (Amsterdam)|October 23, 2010
Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancerLei Gu, Xian-Hua Zhu, Tapio Visakorpi, et al.
European Urology Oncology|May 19, 2019
Patient Experience of Systematic Versus Fusion Prostate BiopsiesJuho T Eineluoto, Petrus Järvinen, Tuomas Kilpeläinen, et al.
Pageof 13